https://www.selleckchem.com/pr....oducts/bevacizumab.h
Children born extremely preterm (EP, less then 28 weeks' gestation) or extremely low birth weight (ELBW, less then 1,000 g) are a vulnerable population at high risk of working memory impairments. We aimed to examine changes in the brain structural connectivity networks thought to underlie working memory performance, after completion of a working memory training program (Cogmed) compared with a placebo program in EP/ELBW children. This was a double-blind, placebo-controlled randomized trial (the Improving Memory in a Preterm Randomis
Beğen
Yorum Yap
Paylaş
